Pathkind Labs is an Indian service provider of diagnostic and related healthcare tests.
Pathkind Labs was authorized by the Indian Council of Medical Research and various state governments to undertake COVID-19 testing.
[5] In response to the COVID-19 pandemic, Pathkind established 10 labs in various cities that provided Covid RT-PCR and other related tests.
This expansion is part of the company's plan to grow its presence in the western and central regions of India, including Maharashtra.
[8] In January 2023, Pathkind Labs and Roche Diagnostics jointly introduced the cardiac biomarker NTProBNP for the detection of heart failure in patients.